Lessons for rituximab therapy in patients with rheumatoid arthritis
Author:
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy,Rheumatology
Reference75 articles.
1. Diagnosis and management of rheumatoid arthritis in adults: summary of updated NICE guidance;Allen;BMJ,2018
2. The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: results of a phase IIB randomized, double-blind, placebo-controlled, dose-ranging trial;Emery;Arthritis Rheum,2006
3. Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a phase III randomized study (MIRROR);Rubbert-Roth;Rheumatology (Oxford),2010
4. Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))
5. Safety and efficacy of additional courses of rituximab in patients with active rheumatoid arthritis: an open-label extension analysis;Keystone;Arthritis Rheum,2007
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A U-Shaped Long-Range Surface Plasmon Resonance (LRSPR) Biosensor With Low Detection Limit;IEEE Sensors Journal;2024-08-01
2. Early predictive factors in routine clinical practice for rituximab therapy response in patients with rheumatoid arthritis;Rheumatology;2024-06-18
3. 2023 Management Recommendations of Bangladesh Rheumatology Society on Pharmacological Treatment of Rheumatoid Arthritis With Synthetic and Biologic Disease-Modifying Drugs;Cureus;2024-04-30
4. Rituximab compared to intravenous cyclophosphamide in adults with connective tissue disease-associated interstitial lung disease: the RECITAL RCT;Efficacy and Mechanism Evaluation;2024-02
5. Nonspecific Orbital Inflammation (NSOI): Unraveling the Molecular Pathogenesis, Diagnostic Modalities, and Therapeutic Interventions;International Journal of Molecular Sciences;2024-01-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3